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1. Introduction 
Alphaz-macroglobulin (osM), a high+& (725 000) 
protein [ 11, is one of the major protease inhibitors in 
human plasma [2]. Classical procedures for its isola- 
tion involve ammonium sulfate and polyethylene 
glycol precipitation followed by gel filtration and/or 
ionexchange chromatography [ 1,3,4]. Most of these 
techniques, which involve several sequential steps, 
result in yields of -20%. In [5] oZM was purified 
from ammonium sulfate precipitate using metal chelate 
chromatography, with an overall 22% recovery. In 
[6] azM was obtained by chromatography of human 
plasma on immobilized Cibacron blue followed by gel 
filtration, with 75% yield. Nevertheless, this proce- 
dure, as most of the others, is only applicable to 
plasma obtained from subjects homozygous for the 
phenotype 1 of haptoglobin, who represent only 20% 
of Caucasian i dividuals [7]. 
We report here a more convenient two-step roce- 
dure for the purification of CQM. Plasma proteins 
are eluted from immobilized Cibacron blue F3GA at 
pH 5 by a salt concentration gradient which separates 
azM from haptoglobin (1, l-2, and 2 phenotypes) 
and immunoglobulin M. The lower-M, contaminants 
can then be removed easily by gel filtration. 
2. Materials and methods 
Human plasma from healthy volunteers with 
haptoglobin phenotypes l , l-2, and 2 was collected 
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on citrate-soybean trypsin inhibitor according to 
[ 11 and centrifuged at 500 X g for 15 min at 4°C; 
20 ml plasma was then dialyzed overnight at 4°C 
against 800 ml CHsCOOH/Na buffer (pH 5.0 at 25’C, 
ionic strength 0.05). 
Affgel blue, a cross-linked agarose gel with 
covalently coupled reactive blue A dye (4.5 ~01 dye/ 
ml), was a generous gift of Bio-Rad Labs. Gel equili- 
brated with the acetate buffer was packed in a column 
(1.6 X 70 cm, Pharmacia Fine Chemicals, Piscataway 
NJ) equipped with plungers. ‘Ihe chromatographic 
experiment was run at room temperature. The flow 
rate was 20 ml/h and fractions of 1.25 ml were col- 
lected at 4°C. After loading of the sample (20 ml 
dialyzed plasma), the column was washed with 75 ml 
of the buffer, and a linear NaCl gradient (from O.O- 
2.0 M in the acetate buffer, total vol. 225 ml) was 
applied using a Pharmacia GM1 0 gradient mixer. 
The column was then washed with an additional 
60 ml 2.0 M NaCl in the acetate buffer. azM-contain- 
ing fractions were pooled, concentrated to 5.0 ml 
under nitrogen pressure, then dialyzed against the 
buffer used for gel filtration. 
Gel filtration experiments were performed at 4°C 
on a column (2.5 X 100 cm) containing 400 ml 
acrylamide-agarose g l (ACA-22, LKB Instruments, 
Rockville MD) equilibrated with 0.1 M H3P04/K 
buffer (pH 6.5) at a flow rate of 10 ml/h. Fractions 
of 2 ml were collected. 
Immunoelectrophoresis, fu ed rocket immuno- 
electrophoresis, and electroimmunoassay were per- 
formed according to [&IO]. Antisera were from 
DAK0 (Accurate Chemical and Scientific, Westbury 
NY). Haptoglobin phenotypes were determined by 
polyacrylamide gel electrophoresis [ 111. The trypsin- 
binding capacity of oZM was measured as in [ 121 
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using soybean trypsln inhibitor and o-N-benzoyl- 
D,Larginine-p-nitroanilide-HCl (BAPNA) all pur- 
chased from Sigma (St Louis MO). Trypsin from Sigma 
(type XI from bovine pancreas) was assayed by active 
site titration as in [ 131 usingp-nitrophenyl-p’guanldo- 
benzoate-HCl (Sigma) and found to be 72% active. 
3. Results and discussion 
A combination of affinity chromatography on 
immobilized Cibacron blue F3GA and gel filtration 
has been proposed [6] for the purification of ozM. 
They fractionated plasma proteins at pH 8.0 on a 
Sepharose matrix to which Cibacron blue was bound 
at the ratio of 2 ~01 dye/ml gel. Under these condi- 
tions, crzM is the first protein to be eluted. Using a 
more substituted matrix (4.5 ~01 dye/ml gel) we 
have shown [ 141 that o,M binds to the gel and is 
eluted only with increasing salt concentrations. 
Under these conditions, CQM is eluted together with 
IgM and haptoglobin. Here, we found that when the 
column was equilibrated at pH 5 most of the plasma 
proteins were bound, but that during elution with a 
salt gradient haptoglobin and IgM were eluted over 
1.25-l .5 M NaCl whereas crzM was eluted over 
1.6-2 M NaCl (fig.1). Haptoglobins of the 1, l-2 
and 2 phenotypes (the latter representing a major 
problem in aaM purification [1,6,15,16]) were eluted 
at the same NaCl molarity (tig.2). Other high-M, com- 
ponents uch as C4, Cl q, and fibrinogen were absent 
from the cuzM elution zone. 
Analysis of the cwzMcontaining fractions by 
immunoelectrophoresis (fig.3) and fused rocket 
immunoelectrophoresis (tIg.2B) indicated that they 
were contaminated with pre-albumin, albumin, C3, 
ceruloplasmin, group-specific component, IgG, and 
monomeric IgA. All these contaminants were 
removed by an additional step of gel filtration on 
ACA-22 (fig.lB). CQM was eluted ahead of the 
lower-Mr proteins and did not overlap with them as 
shown by fused rocket immunoelectrophoresis 
tube number 
tube number 
Fig.1. (A) Absorbance at 280 nm of plasma fractions obtained by chromatography on Affigel blue at pH 5. The bar indicates the 
position where CC,M was eluted. (B) Elution prof$e for the a,Mcontaining fractions from A (tubes 176-225) after gel filtration 
on ACA-22. The bar indicates the position where CQM was eluted. The difference in overall A,,, between the two profiles is due 
to the different light path of the cells used. 
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(fig.2B) and by immunoelectrophoresis (f g.3). Deter- 
mination of the yield by Laurell rocket immuno- 
electrophoresis and measurement of trypsin-inhibitory 
capacity is indicated in table 1. During the process of 
purification (despite xposure of oZM to pH 5) no 
significant modification of the trypsig_binding capacity 
of ozM occurred, and the purified protein retained its 
functional properties. 
The purification procedure we have described 
appears to have several advantages over previously 
reported techniques: 
(1) It does not involve time-consuming or denaturing 
steps, and the chromatographic gels used are 
commercially available. 
A 
Fig.2. (A) Fused rocket immunoelectrophoresis of plasma fractions eluted from the Affigel blue column. Conditions: 1% agarose 
in barbital buffer (PI-I 8.6) containing total antihuman antiserum (DAKO) 50 rd/rnl. Sample deposition: 3 rl. Run for 3 h at 
350 V. (B) Fused rocket immunoelectrophoresis of the fractions eluted from the ACA-22 column. Bottom layer: antiserum to 
oaM, 10 r.d/ml (oo,M). Top layer: total antihuman antiserum, 20 ~l/ml (S). (C) Fused rocket immunoelectrophoresis showing 
the separation between haptoglobin (phenotype 2-2) and a,M on Affigel blue. 
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Fig.3. Immunoelectrophoresis of whole plasma, fractions 
containing cu,M from the Aftigel blue column (tubes 176- 
225), and fractions containing ar,M from the ACA-22 col- 
umn (tubes 100-120). (YS, total antihuman antiserum; oa,M, 
antiserum to or,M. 
(2) It is applicable to plasma obtained from donors 
either homozygous or heterozygous for the 2 
variant of haptoglobin. 
(3) It provides azM with an overall yield of 60% and 
,with preservation of its biological activity. This 
is important in view of the continuing interest in 
the structure and biological role of cxzM [171, 
not only as a protease inhibitor but also as a
modulator gf the immune response [ 18,191. 
Our procedure illustrates the versatility of 
pseudoligand affnity chromatography asa tool 
for the fractionation of human plasma proteins 
[6,14,20,21]. 
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Table 1 
o,M concentration, biological activity and yields after the different purification 
steps 
Material Vol. 
(ml) 
Yield 
(%) 
Trypsin 
binding 
capacityb 
Yield 
(%) 
Dialyzed 
human 
plasma 20 250 100 0.410 100 
Pool of 
AffIgel blue 
fractions 
(176-225) 62.5 64 80 0.104 79.2 
Pool of 
ACA 22 
fractions 
(100-120) 40 75 60 0.120 58.5 
a o,M concentration measured by Laurell rocket immunoelectrophoresis [ 10 ] 
using a protein standard obtained from Calbiochem-BehrIng (La Jolla CA; lot 
no. 75425) 
b Trypsin binding capacity measured as in [ 121. The reaction between bound 
trypsin and BAPNA was stopped after 15 min incubation 
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